Evaluation of long-term outcomes with intrathecal opioid treatment: a comparison utilizing data derived from pain clinic populations in Australia and New Zealand.
Elouise Rose Comber, Jenny Strong, Orla Moore, Asaduzzaman Khan, James O'Callaghan, Benjamin Manion, Brendan Joseph Moore, Maree Therese Smith
{"title":"Evaluation of long-term outcomes with intrathecal opioid treatment: a comparison utilizing data derived from pain clinic populations in Australia and New Zealand.","authors":"Elouise Rose Comber, Jenny Strong, Orla Moore, Asaduzzaman Khan, James O'Callaghan, Benjamin Manion, Brendan Joseph Moore, Maree Therese Smith","doi":"10.3389/fpain.2025.1527371","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>An obstacle to analysis of the long-term effectiveness of intrathecal (IT) opioids is absence of historical patient baseline data. The electronic Persistent Pain Outcomes Collaboration (ePPOC) is an initiative of the Faculty of Pain Medicine of the Australian and New Zealand College of Anaesthetists. Recently published ePPOC data has provided justifiable surrogate baseline data allowing opportunities for pain outcomes research into select patient treatment groups. Our aim was to compare long-term outcomes of IT opioid therapy with a surrogate baseline utilizing a large ePPOC data set for patients at the time of initial presentation to 36 pain clinics in Australia and New Zealand.</p><p><strong>Methods: </strong>Study participants were 49 consenting patients receiving IT opioids as part of a long-term pain management regime for treating chronic non-cancer pain. Their data were compared with the large ePPOC data set (<i>n</i> = 13,343). The questionnaires comprised a demographic questionnaire, the Brief Pain Inventory, the Depression, Anxiety and Stress Scale, the Pain Catastrophizing Questionnaire, and the Pain Self-Efficacy Questionnaire.</p><p><strong>Results: </strong>Compared with the ePOCC group, participants who received IT opioids long-term for the relief of chronic non-cancer pain reported significantly lower (<i>p</i> ≤ 0.001) pain severity (4.3 vs. 6.4), and pain interference scores (5.5 vs. 7), significantly lower depression (20.2 vs. 13.7), anxiety (9.6 vs. 14.1), stress (15.5 vs. 21), rumination (6.9 vs. 10), magnification (3.8 vs. 5.9), helplessness (9.7 vs. 14.1), general catastrophizing (20.4 vs. 29.8), and higher self-efficacy (29.5 vs. 20.7).</p><p><strong>Discussion: </strong>The observed improvements in all measured pain variables have occurred in the context of comprehensive pain management, and therefore, may be attributable to pain reduction and not directly to IT opioid use or the device itself. Favourable pain management outcomes, in a select patient treatment group utilizing long-term IT opioid therapy, were demonstrated using the large-data ePPOC initiative, highlighting the research opportunities it provides.</p>","PeriodicalId":73097,"journal":{"name":"Frontiers in pain research (Lausanne, Switzerland)","volume":"6 ","pages":"1527371"},"PeriodicalIF":2.5000,"publicationDate":"2025-02-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11868084/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in pain research (Lausanne, Switzerland)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3389/fpain.2025.1527371","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: An obstacle to analysis of the long-term effectiveness of intrathecal (IT) opioids is absence of historical patient baseline data. The electronic Persistent Pain Outcomes Collaboration (ePPOC) is an initiative of the Faculty of Pain Medicine of the Australian and New Zealand College of Anaesthetists. Recently published ePPOC data has provided justifiable surrogate baseline data allowing opportunities for pain outcomes research into select patient treatment groups. Our aim was to compare long-term outcomes of IT opioid therapy with a surrogate baseline utilizing a large ePPOC data set for patients at the time of initial presentation to 36 pain clinics in Australia and New Zealand.
Methods: Study participants were 49 consenting patients receiving IT opioids as part of a long-term pain management regime for treating chronic non-cancer pain. Their data were compared with the large ePPOC data set (n = 13,343). The questionnaires comprised a demographic questionnaire, the Brief Pain Inventory, the Depression, Anxiety and Stress Scale, the Pain Catastrophizing Questionnaire, and the Pain Self-Efficacy Questionnaire.
Results: Compared with the ePOCC group, participants who received IT opioids long-term for the relief of chronic non-cancer pain reported significantly lower (p ≤ 0.001) pain severity (4.3 vs. 6.4), and pain interference scores (5.5 vs. 7), significantly lower depression (20.2 vs. 13.7), anxiety (9.6 vs. 14.1), stress (15.5 vs. 21), rumination (6.9 vs. 10), magnification (3.8 vs. 5.9), helplessness (9.7 vs. 14.1), general catastrophizing (20.4 vs. 29.8), and higher self-efficacy (29.5 vs. 20.7).
Discussion: The observed improvements in all measured pain variables have occurred in the context of comprehensive pain management, and therefore, may be attributable to pain reduction and not directly to IT opioid use or the device itself. Favourable pain management outcomes, in a select patient treatment group utilizing long-term IT opioid therapy, were demonstrated using the large-data ePPOC initiative, highlighting the research opportunities it provides.
分析鞘内(IT)阿片类药物长期有效性的一个障碍是缺乏历史患者基线数据。电子持续疼痛结果协作(ePPOC)是澳大利亚和新西兰麻醉师学院疼痛医学学院的一项倡议。最近发表的ePPOC数据提供了合理的替代基线数据,为选择患者治疗组进行疼痛结局研究提供了机会。我们的目的是利用澳大利亚和新西兰36家疼痛诊所的患者首次就诊时的大型ePPOC数据集,比较IT阿片类药物治疗与替代基线的长期结果。方法:研究参与者是49名同意接受IT阿片类药物作为治疗慢性非癌性疼痛的长期疼痛管理方案的一部分的患者。将他们的数据与大型ePPOC数据集(n = 13,343)进行比较。问卷包括人口统计问卷、疼痛简易量表、抑郁、焦虑和压力量表、疼痛灾难化问卷和疼痛自我效能问卷。结果:与ePOCC组相比,长期服用IT阿片类药物缓解慢性非癌性疼痛的参与者报告的疼痛严重程度(4.3 vs. 6.4)和疼痛干扰评分(5.5 vs. 7)显著降低(p≤0.001),抑郁(20.2 vs. 13.7)、焦虑(9.6 vs. 14.1)、压力(15.5 vs. 21)、沉思(6.9 vs. 10)、放大(3.8 vs. 5.9)、无助(9.7 vs. 14.1)、一般灾难化(20.4 vs. 29.8)显著降低,自我效能(29.5 vs. 20.7)显著降低。讨论:观察到的所有测量疼痛变量的改善都发生在全面疼痛管理的背景下,因此,可能归因于疼痛减轻,而不是直接归因于IT阿片类药物的使用或设备本身。使用大数据ePPOC计划,在使用长期IT阿片类药物治疗的选定患者治疗组中,证明了良好的疼痛管理结果,突出了它提供的研究机会。